CTConsuelo Treviño-Garza

Consuelo Treviño-Garza

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Consuelo Treviño-Garza has a total of 112 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Vitamin D deficiency in Mexican mothers and their newborns

    by Erika del Carmen Ochoa-Correa, Pedro Alberto García-Hernández, Jesús Zacarías Villarreal-Pérez, Consuelo Treviño-Garza, Isaías Rodrí­guez-Balderrama, Laura Elia Martínez-De Villarreal, Carlos Alberto Zapata-Castilleja


  • Open Access

    Seroprevalence of Anti-SARS-CoV-2 Antibodies in Blood Donors from Nuevo Leon State, Mexico, during 2020: A Retrospective Cross-Sectional Evaluation

    by Natalia Martinez-Acuña, Diana Minerva Avalos-Nolazco, Diana Raquel Rodriguez-Rodriguez, Cynthia Gabriela Martinez-Liu, Kame Alberto Galan-Huerta, Gerardo Raymundo Padilla-Rivas, Javier Ramos-Jimenez, Sergio Ayala-De-La-Cruz, Eduardo Cienfuegos-Pecina, Erik Alejandro Diaz-Chuc, et al.

    The progression and distribution of the SARS-CoV-2 pandemic are continuously changing over time and can be traced by blood donors’ serological survey. Here, we investigated the seroprevalence of anti-SARS-CoV-2 antibodies in blood donors in Nuevo Leon, Mexico during 2020 as a strategy for the rapid evaluation of the spread of SARS-CoV-2 and asymptomatic case detection. We collected residual plasma samples from blood donors who attended two regional donation centers from January to December of 2020 to identify changes in anti-SARS-CoV-2 IgG prevalence. Plasma samples were analyzed on the Abbott Architect instrument using the commercial Abbott SARS-CoV-2 IgG chemiluminescent assay. We found a total of 99 reactive samples from 2068 analyzed plasma samples, resulting in a raw prevalence of 4.87%. Donors aged 18–49 years were more likely to be seropositive compared to those aged >50 years (p < 0.001). Weekly seroprevalence increased from 1.8% during the early pandemic stage to 27.59% by the end of the year. Prevalence was 1.46-fold higher in females compared to males. Case geographical mapping showed that Monterrey city recorded the majority of SARS-CoV-2 cases. These results show that there is a growing trend of seroprevalence over time associated with asymptomatic infection that is unnoticed under the current epidemiological surveillance protocols.


  • Open Access

    Prevalence of IgG antibodies induced by the SARS‐COV‐2 virus in asymptomatic adults in Nuevo Leon, Mexico

    by Edgar P. Rodríguez‐Vidales, Denise Garza‐Carrillo, José J. Pérez‐Trujillo, Olivia A. Robles‐Rodríguez, Ana María Salinas‐Martínez, Roberto Montes de Oca‐Luna, Consuelo Treviño‐Garza, Manuel E. De la O‐Cavazos

    Population‐based immunoglobulin G (IgG) seroprevalence studies in asymptomatic individuals in Latin America are scarce. The objective of the study was to estimate the prevalence and geographic distribution of IgG antibodies induced by natural SARS‐CoV‐2 infection in asymptomatic adults, 5–8 months after the first case was reported in a northeastern state of Mexico. This was a population‐based cross‐sectional study carried out in Nuevo Leon during August–November 2020. Individuals ≥18 years with no previous diagnosis or symptoms suggestive of COVID‐19 were consecutively screened in one of the busiest subway stations. Also, a search for eligible individuals was done from house‐to‐house, after selecting densely populated geographic sectors of each of the municipalities of the metropolitan area (n = 4495). The IgG antibodies to SARS‐CoV‐2 nucleocapsid protein were analyzed. The IgG antibody positivity rate was 27.1% (95% confidence interval [CI]: 25.8, 28.4); there were no differences by sex or age (p > 0.05). Analysis by month showed a gradual increase from 11.9% (August) to 31.9% (November); Week 39 had the highest positivity rate (42.2%, 95% CI: 34.2, 50.7). Most people did not have evidence of previous SARS‐CoV‐2 infection. Preventive measures and promotion of the COVID‐19 vaccine should be strengthened.


  • Open Access

    Decline in influenza cases in Mexico after the implementation of public health measures for COVID-19

    by Daniel Arellanos-Soto, Gerardo Padilla-Rivas, Javier Ramos-Jimenez, Kame Galan-Huerta, Sonia Lozano-Sepulveda, Natalia Martinez-Acuña, Consuelo Treviño-Garza, Roberto Montes-De-Oca-Luna, Manuel De-La-O-Cavazos, Ana Maria Rivas-Estilla

    Mexico took swift action and has strictly followed mitigation measures to prevent the spread of coronavirus disease, COVID-19. In this study we compared influenza activity indicators in our country after the implementation of public health measures for COVID-19. We compared indicators of influenza activity in 2020 before and after public health measures were taken to reduce COVID-19 with the corresponding indicators from three preceding years and the immediate one, and the potential decrease in seasonal influenza cases/deaths. Nationwide surveillance data revealed a drastic decline in influenza diagnosis in outpatient clinics and public hospitals, influenza positivity rates of clinical specimens, and confirmed severe cases during the following 10 weeks of 2020 as lockdown activities and control measures were established compared with the same period of 2019. Our results suggest that the measures taken for COVID-19 were effective in reducing the spread of other viral respiratory diseases as influenza in our country.


  • Open Access

    Detection of two CAL.20C SARS-CoV-2 variants in Monterrey metropolitan area in Northeast Mexico

    by Kame A. Galán-Huerta, Ana M. Rivas-Estilla, Sonia A. Lozano-Sepúlveda, Natalia Martínez-Acuña, Daniel Arellanos-Soto, Roberto Montes-De-Oca-Luna, Consuelo Treviño-Garza, Manuel E. De-La-O-Cavazos, Javier Ramos-Jiménez

    SARS-CoV-2 variants of concern (VOC) are a worldwide problem. CAL.20C is considered a VOC and its distribution should be monitored. We detected two CAL.20C variants in Monterrey, Mexico in patients who had no recent travel history. This indicates that this variant is now transmitted locally in Northeast Mexico.

  • Open Access

    Seroprevalence of anti-SARS-COV-2 antibodies in blood donors from Nuevo Leon state, Mexico, during the beginning of the COVID-19 pandemic

    by Natalia Martinez-Acuña, Diana Avalos-Nolazco, Diana Rodriguez-Rodriguez, Cynthia Martinez-Liu, Rogelio Cazares Taméz, Amador Flores-Arechiga, Fernando Perez-Chavez, Sergio Ayala-De-La-Cruz, Eduardo Cienfuegos-Pecina, Erik Diaz-Chuc, et al.

    Summary: Background: The progression and distribution of SARS-CoV-2 is unknown because typically only symptomatic individuals are diagnosed. Aim: We evaluated the seroprevalence of anti-SARS-CoV-2 in blood donors in Nuevo Leon, Mexico as a strategy for asymptomatic case detection of COVID-19 and epidemic progression. Methods/Materials: We tested 1968 blood donors that attended two regional donation centers in Northeast Mexico from January 1 st to August 30, 2020, to identify anti-SARS-CoV-2 IgG by chemiluminescent immunoassay. Additionally, routine tests for donors including Brucella, Chagas, HCV, VDRL, HIV-1, and HBsAg identification were performed. Results: We found 77 donors reactive for anti-SARS-CoV-2 IgG (seroprevalence 3.99%) and none of them had reported recent COVID-19 symptoms. Donors aged 18 to 49 years (89.5%) were more likely to be seropositive compared to those aged 50 years or older (10.5%) (P<0.001). Prevalence of antibodies increased each epidemiological (EPI) week, parallel to the report of confirmed cases by RT-PCR, identifying the highest prevalence between EPI week 33 and 35 (10.2% to 19%). The metropolitan area of Monterrey recorded the highest number of cases. Routine tests showed that the prevalence of anti-Brucella was 0.13%, anti-HCV 0.5%, anti-HIV-1-2 0.14%, HBsAg 0.16%, Chagas 0.48% and syphilis 1.06%. Conclusions: There is a growing trend of seroprevalence over time, parallel to the constantly increasing epidemic curve in our region and it was higher under 49 years of age associated with asymptomatic infection in donors from the Nuevo Leon area. Detection of anti-SARS-CoV-2 in blood donors is a potential tool for tracking the progression and identifying population exposure during the SARS-CoV-2 outbreak.


  • Open Access

    Decline in influenza cases in Mexico after the implementation of public health measures for COVID-19

    by Arellanos-Soto Daniel, Padilla-Rivas Gerardo, Ramos-Jimenez Javier, Galan-Huerta Kame, Lozano-Sepulveda Sonia, Martinez-Acuña Natalia, Treviño-Garza Consuelo, De la O-Cavazos Manuel, Montes de Oca-Luna Roberto, Rivas-Estilla Ana Maria

    Mexico took swift action and has strictly followed mitigation measures to prevent the spread of coronavirus disease, COVID-19. The present study compared indicators of influenza activity in 2020 before and after public health measures were taken to reduce COVID-19 with the corresponding indicators from three preceding years and the immediate one, and the potential decrease in seasonal influenza cases. Nationwide surveillance data revealed a drastic decline in influenza diagnosis in outpatient clinics and public hospitals, positivity rates of clinical specimens, and confirmed severe cases during the following 10 weeks of 2020 as lockdown activities and control measures were established compared with the same period of 2019, suggesting that the measures taken for COVID-19 were effective in reducing the spread of other viral respiratory diseases in our country.

  • Predicting the optimal depth of ultrasound-guided right internal jugular vein central venous catheters in neonates

    by Fernando Montes-Tapia, Karla Hernández-Trejo, Fernando García-Rodríguez, Julio Jaime-Reyes, Consuelo Treviño-Garza, Barbara Cárdenas-Del Castillo, Isaías Rodríguez- Balderrama, Manuel de la O-Cavazos


  • Open Access

    Analgesic effects of maternal breast milk and sucrose in early, full, and late-term neonates

    by Brenda B. Pérez-Méndez, Erika del C. Ochoa-Correa, Consuelo Treviño-Garza, Dolores C. Cortés-Flores, Jaime I. Bocanegra-Cedillo, Anahí Flores-Rodríguez, Isaías Rodríguez-Balderrama, Manuel E. de la O-Cavazos

  • Differences in omentin-1 levels in term newborns according to birth weight

    by Citlalli E. Hernández-Rodríguez, Cynthia M. Estrada-Zúñiga, Manuel E. De la O-Cavazos, Fernando García-Rodríguez, Isaías Rodríguez-Balderrama, Carlos A. Zapata-Castilleja, Consuelo Treviño-Garza